cationic liposomes

Topical Administration of Mucoadhesive Liposomes−Epoetin‑β forTargeting the Ocular Posterior Segment

🔬 Introduction Delivering therapeutic agents to the posterior segment of the eye remains one of the greatest challenges in ophthalmology. Diseases such as glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy primarily affect the retina and optic nerve, often leading to irreversible vision loss. Conventional delivery methods—including intravitreal injections and systemic administration—are either invasive or […]

Topical Administration of Mucoadhesive Liposomes−Epoetin‑β forTargeting the Ocular Posterior Segment Read Post »

Stabilization of cationic liposomes using hyaluronic acid-modified gold nanoparticles by post-microfluidics conjugation approach for drug delivery applications

Introduction A major challenge in liposomal drug delivery is the poor stability of cationic liposomes in physiological conditions. To address this, researchers developed a hybrid system combining hyaluronic acid-modified gold nanoparticles (HA-AuNPs) with cationic liposomes. This innovative surface engineering strategy improves liposome stability while preserving their drug delivery potential — especially for cancer therapies. 💡

Stabilization of cationic liposomes using hyaluronic acid-modified gold nanoparticles by post-microfluidics conjugation approach for drug delivery applications Read Post »

Scroll to Top